COVAXIN effective against COVID-19 Delta variant, confirms ICMR

New Delhi : In good news, ICMR study has confirmed that Bharat Biotech's COVAXIN is pretty much effective against the deadlier Delta variant of coronavirus.

Covaxin was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) National Institute of Virology (NIV).

Covaxin is among the three vaccines which are being currently administered in India; other than this COVISHIELD and SPUTNIK V are available for general public.

Earlier, as per the news reports, Bharat Biotech had said that Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.

According to the latest developments, on Tuesday, all documents required for Emergency Use Listing (EUL) were submitted to World Health Organisation (WHO) by Bharat Biotech for Covaxin as of July 9 and the review process by the agency had commenced, Minister of State for Health Bharati Pravin Pawar informed Rajya Sabha.

Meanwhile, India is registering an average of 40,000 daily coronavirus cases since last one week.